|
|
|
Novartis receives approval from FDA to market Prevacid® 24HR as first and only OTC proton pump inhibitor in original prescripti
May 19, 2009
This approval will provide greater convenience and broader access to an effective treatment option to the 50 million Americans1 suffering from frequent heartburn
|
|
|